BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1446 related articles for article (PubMed ID: 10599552)

  • 1. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels.
    Milewicz A; Bidzińska B; Mikulski E; Demissie M; Tworowska U
    Gynecol Endocrinol; 2000 Jun; 14(3):196-203. PubMed ID: 10923281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women.
    Baranowska B; Wolińska-Witort E; Martyńska L; Chmielowska M; Baranowska-Bik A
    Neuro Endocrinol Lett; 2005 Aug; 26(4):293-6. PubMed ID: 16135994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders.
    Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Martynska L; Chmielowska M
    Neuro Endocrinol Lett; 2003 Dec; 24(6):431-4. PubMed ID: 15073570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa.
    Baranowska B; Wolinska-Witort E; Wasilewska-Dziubinska E; Roguski K; Chmielowska M
    Neuro Endocrinol Lett; 2001 Oct; 22(5):356-8. PubMed ID: 11600878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of adiposity on leptin, LH and androgen levels in lean, overweight and obese PCOS patients.
    LaZovic G; Radivojevic U; Milicevic S; Spremovic S
    Int J Fertil Womens Med; 2007; 52(2-3):82-8. PubMed ID: 18320865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between neuropeptides and hormones in starvation.
    Baranowska B; Chmielowska M; Wolinska-Witort E; Roguski K; Wasilewska-Dziubinska E
    Neuro Endocrinol Lett; 2001 Oct; 22(5):349-55. PubMed ID: 11600877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal levels of leptin, insulin, ghrelin, and neuropeptide Y in lean, overweight, and obese Saudi females.
    Daghestani MH; Ozand PT; Al-Himadi AR; Al-Odaib AN
    Saudi Med J; 2007 Aug; 28(8):1191-7. PubMed ID: 17676200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.